| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Anti-inhibitor coagulant complex |
Is a |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Microfibrillar collagen hemostat |
Is a |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Absorbable gelatin film |
Is a |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Absorbable gelatin powder |
Is a |
True |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Eptacog alfa (substance) |
Is a |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Thrombin agent |
Is a |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Factor IX complex |
Is a |
True |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Aminocaproic acid |
Is a |
True |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Human antihemophilic plasma |
Is a |
True |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Carbazochrome salicylate |
Is a |
True |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Plasma substitutes (substance) |
Is a |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Coagulant (substance) |
Is a |
True |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Antihemophilic factor agent (substance) |
Is a |
True |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Local application of hemostyptics onto gastric lesion |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
1 |
| traitement par injection d'une lésion de duodénum |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Local application of haemostyptics onto duodenal lesion |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
1 |
| agent hémostatique |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Haemostatic adverse reaction |
Causative agent (attribute) |
True |
Hemostatic agent (substance) |
Inferred relationship |
Some |
1 |
| Ethamsylate adverse reaction |
Causative agent (attribute) |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Collagen adverse reaction |
Causative agent (attribute) |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Allergy to hemostatic agent |
Causative agent (attribute) |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Allergy to etamsylate |
Causative agent (attribute) |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Allergy to collagen (finding) |
Causative agent (attribute) |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Endoscopic application of hemostyptics to gastric lesion |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
2 |
| injection hémostatique d'une lésion duodénale |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| injection hémostatique d'une lésion gastrique |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
1 |
| injection d'adrénaline à visée hémostatique pour une lésion gastrique |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
2 |
| Injection of epinephrine into lesion of duodenum for hemostasis |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Endoscopic injection haemostasis of duodenal ulcer |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
1 |
| Endoscopic injection haemostasis of gastric ulcer |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Fibrinolytic drugs |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Antifibrinolytic drugs and hemostatics |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Product containing etamsylate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| étamsylate 250 mg/2 mL, pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Etamsylate 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Collagen [hemostatic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Product containing human fibrinogen and thrombin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Desmopressin acetate 10 microgram/actuation nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Desmopressin acetate 100 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Desmopressin acetate 200 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Desmopressin acetate 100micrograms/1mL intranasal solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| acétate de desmopressine 4 microgrammes/mL, ampoule de 1 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Succinylated gelatin 4% infusion solution bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Product containing collagen (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Application of chemical hemostatic agents (procedure) |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
1 |
| Factor IX complex 100% powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Desmopressin acetate 1.5mg/mL spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Antihemophilic factor 500unt/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Desmopressin acetate 0.01% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Desmopressin acetate 0.1mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Desmopressin acetate 0.2mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Desmopressin acetate 0.1mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Desmopressin acetate 0.01% spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Tranexamic acid (substance) |
Is a |
True |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Aprotinin (substance) |
Is a |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Tissue factor, the high-affinity receptor and cofactor for the plasma serine protease VII/VIIa |
Is a |
True |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Etamsylate (substance) |
Is a |
True |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Product containing desmopressin acetate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Product containing antihemophilic factor agent (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Product containing desmopressin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Product containing factor VIII fraction |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Product containing factor IX fraction |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| facteur IX de coagulation recombinant 250 U.I., fiole de poudre et solvant pour solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| facteur IX de coagulation recombinant 500 U.I., fiole de poudre et solvant pour solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| facteur IX de coagulation recombinant 1 000 U.I., fiole de poudre et solvant pour solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Product containing coagulation factor VIIa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| facteur VIIa de coagulation recombinant 60 000 U.I., fiole de poudre et solvant pour solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| facteur VIIa de coagulation recombinant 120 000 U.I., fiole de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| facteur VIIa de coagulation recombinant 240 000 U.I., fiole de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Coagulation factor VIII- and von Willebrand factor-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| facteur VIII 500 U.I./facteur von Willebrand 1 100 U.I.,fiole de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| facteur VIII 1 000 U.I./facteur von Willebrand 2 200 U.I., fiole de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Product containing coagulation factor XIII (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| facteur XIII 250 unités, fiole de poudre et solvant pour solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| facteur XIII 1 250 unités, fiole de poudre et solvant pour solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Acset |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Product containing high purity factor IX |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Intermediate factor IX |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Product containing anti-inhibitor coagulant complex (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Product containing factor IX concentrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Factor V concentrate products |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| facteur VII |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Deoxyribonucleic acid factor VIII |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Product containing high purity factor VIII |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Intermediate factor VIII |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Product containing porcine factor VIII (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Coagulation factor II- and coagulation factor IX- and coagulation factor VIIa- and coagulation factor VIII- and coagulation factor X-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Product containing coagulation factor XI (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Product containing von Willebrand factor (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Dried factor IX fraction heated 600iu powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Factor VIII by-passing fraction 500iu powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Factor VIII by-passing fraction 1000iu powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| High purity factor VIII fraction 250iu powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| High purity factor VIII fraction 500iu powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| High purity factor VIII fraction 1000iu powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Intermediate factor VIII fraction 250iu powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Intermediate factor VIII fraction 500iu powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Porcine factor VIII 700iu powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| High purity factor IX 250iu powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| High purity factor IX 500iu powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| High purity factor IX 1000iu powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]